key: cord-0788042-hyabyemn
authors: Pairo-Castineira, E.; Clohisey, S.; Klaric, L.; Bretherick, A.; Rawlik, K.; Parkinson, N.; Pasko, D.; Walker, S.; Richmond, A.; Head Fourman, M.; Law, A.; Furniss, J.; Gountouna, E.; Wrobel, N.; Russell, C. D.; Moutsianas, L.; Wang, B.; Meynert, A.; Yang, Z.; Zhai, R.; Zheng, C.; Griffith, F.; Oosthuyzen, W.; Shih, B.; Keating, S.; Zechner, M.; Haley, C.; Porteous, D. J.; Hayward, C.; van Heel, D.; Barrett, J. C.; Knight, J.; Summers, C.; Shankar-Hari, M.; Turtle, L.; Ho, A.; Hinds, C.; Horby, P.; Nichol, A.; Maslove, D.; Ling, L.; Klenerman, P.; McAuley, D.; Montgomery, H.; Walsh, T.; Gen, The
title: Genetic mechanisms of critical illness in Covid-19
date: 2020-09-25
journal: nan
DOI: 10.1101/2020.09.24.20200048
sha: f17b0870764ad1951e4c4bc413d323279cbce2db
doc_id: 788042
cord_uid: hyabyemn

The subset of patients who develop critical illness in Covid-19 have extensive inflammation affecting the lungs and are strikingly different from other patients: immunosuppressive therapy benefits critically-ill patients, but may harm some non-critical cases. Since susceptibility to life-threatening infections and immune-mediated diseases are both strongly heritable traits, we reasoned that host genetic variation may identify mechanistic targets for therapeutic development in Covid-19. GenOMICC (Genetics Of Mortality In Critical Care, genomicc.org) is a global collaborative study to understand the genetic basis of critical illness. Here we report the results of a genome-wide association study (GWAS) in 2790 critically-ill Covid-19 patients from 208 UK intensive care units (ICUs), representing >95% of all ICU beds. Random controls were drawn from three distinct UK population studies. We identify and replicate several novel genome-wide significant associations including variants chr19p13.3 (rs2109069, P = 3.98 x 10-12), within the gene encoding dipeptidyl peptidase 9 (DPP9), and at chr21q22.1 (rs2236757, P = 4.99 x 10-8) in the interferon receptor IFNAR2. Consistent with our focus on extreme disease in younger patients with less comorbidity, we detect a stronger signal at the known 3p21.31 locus than previous studies (rs73064425, P = 1.2 x 10-27). We identify potential targets for repurposing of existing licensed medications. Using Mendelian randomisation we found evidence in support of a causal link from low expression of IFNAR2, and high expression of TYK2, to life-threatening disease. Transcriptome-wide association in lung tissue revealed that high expression of the monocyte/macrophage chemotactic receptor CCR2 is associated with severe Covid-19. We detected genome-wide significant gene-level associations for genes with central roles in viral restriction (OAS1, OAS2, OAS3). These results identify specific loci associated with life-threatening disease, and potential targets for host-directed therapies. Randomised clinical trials will be necessary before any change to clinical practice.

: Baseline characteristics of patients included. Significant comorbidity was defined as the presence of functionally-limiting comorbid illness in GenOMICC, in the assessment of the treating clinicians. In ISARIC 4C significant comorbidity refers to the presence of any chronic cardiac, lung, kidney, or liver disease, cancer or dementia. Age is shown as mean ± standard deviation. 5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020 . . https://doi.org/10.1101 excluded. In addition to the locus on chr3 already reported (rs73064425, OR=2.14, discovery p=4.77 × 10 -30 ), 147 we found robust replication for the novel associations in three loci from GenOMICC: two loci on chromosome 148 19, containing genes OAS3 (rs74956615, OR=1.59, discovery p= 1.65 × 10 -8 ) and DPP9 (rs2109069, OR=1.36, 149 discovery p=3.98 × 10 -12 ) and locus on chromosome 21, containing gene IFNAR2 (rs2236757, OR=1.28, p=5 150 × 10 -8 ) (Table 3) . 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . Mendelian randomisation provides evidence for a causal relationship between an exposure variable and an 158 outcome, given a set of assumptions. 21 We employ it here to assess the evidence in support of causal effects 159 of RNA expression of various genes on the odds of critical Covid-19. 160 We specified an a priori list of target genes that relate to the mechanism of action of many host-targeted drugs 161 that have been proposed for the treatment of Covid-19 (Supp Table 1 We performed TWAS 23,24 to link GWAS results to tissue-specific gene expression data by inferring gene 179 expression from known genetic variants that are associated with transcript abundance (expression quantitative 180 trait loci, eQTL). For this analysis we used GTExv8 data for two disease-relevant tissues chosen a priori: Genetic correlations, tissue, and cell-type associations 187 We tested for genetic correlations with other traits, that is the degree to which the underlying genetic Host Genetics initiative, which has been generously shared with the international community. Likewise, full 210 summary statistics from GenOMICC are openly available in order to advance the rate of discovery.

Despite the differences in case definitions, novel associations from our study of critical illness replicate robustly 212 in the hospitalised case study (Table 3) . Separately, the Mendelian randomisation results implying a causal 213 role for IFNAR2 and TYK2 are also statistically significant in this cohort. Our findings reveal that critical 214 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . https://doi.org/10.1101/2020.09.24.20200048 doi: medRxiv preprint a. b. Figure 3 : Summary of TWAS results. a. Gene-level Manhattan plot showing results from meta-TWAS analysis across tissues. b. z-scores showing direction of effect for genotype-inferred expression of transcripts encoding protein-coding genes in lung tissue (GTEXv8). Red highlighting indicates genome-wide significance at p < 5 × 10 -6 . 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . https://doi.org/10.1101/2020.09.24.20200048 doi: medRxiv preprint illness in Covid-19 is related to at two biological mechanisms: innate antiviral defences (interferon and OAS Increased expression of the interferon receptor subunit IFNAR2 reduced the odds of severe Covid-19 with 217 Mendelian randomisation discovery p = 0.0043 (7 tests); replication p = 0.0066 (1 test). Within the assump-218 tions of Mendelian randomisation, this represents evidence for a protective role for IFNAR2 in Covid-19. 219 We deemed this gene to be therapeutically-informative a priori because it is a target for exogenous inter- Our results also reveal genes that may act to drive inflammatory organ injury. TYK2 is one of 4 gene products 229 listed in the druggable genome Targets Central Resource Database 37 as a target for baricitinib, one of the 230 nine candidate drugs we used in the creation of our a priori target list (Supplementary Table 1 ). However, 231 since we did not a priori include TYK2 on the final set of genes for focused Mendelian randomisation, we 232 use a significance threshold corrected for the full set of comparisons: discovery p = 0.00049 (4614 tests); 233 replication p = 0.0022 (9 tests).

The association in 19p13.3 (rs2109069, p = 3.98 × 10 12 ) is an intronic variant in the gene encoding dipeptidyl The ABO locus was also previously associated with Covid-19, 10 but was not significant in our study (smallest Analysis of shared heritability highlights adiposity and educational attainment: genetically increased body 256 mass index (BMI) and genetically decreased educational attainment are both associated with higher risk 257 severe Covid. This does not imply a causal relationship, as a number of biases may be at play, but may 258 reflect the fact that increased BMI and lower socio-economic status are strong risk factors for 46, 47 259 or the fact that UK Biobank participants were disproportionately drawn from a high socio-economic status 260 group. 48

There is an urgent need to deepen these findings through further studies of this type, with harmonised 262 integration across multiple studies. We continue to recruit to the GenOMICC study, in the expectation that 263 additional associations exist and can be detected with larger numbers of cases. Future studies using whole 264 10 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . genome sequencing will add spatial resolution on the genome and better detection rare variants. Our cohort 265 is strongly enriched for immediately life-threatening disease in patients who are either receiving invasive 266 mechanical ventilation, or considered by the treating physicians to be at high risk of requiring mechanical 267 support. With 2244 cases we have statistical power to detect strong effects, such as the highly-significant 268 locus at 3p21.31, as well as moderate genome-wide significant findings with external replication at DPP9 and 269 IFNAR2.

Because of the urgency of completing and reporting this work, we have drawn controls from population 271 genetic studies who were genotyped using different technology from the cases. We mitigated the consequent 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. were re-suspended in 1 ml TE buffer pH 7.5 (10mM Tris-Cl pH 7.5, 1mM EDTA pH 8.0). The yield of the 294 DNA was measured using Qubit and normalised to 50ng/ l before genotyping.

Genotyping was performed using the Illumina Global Screening Array v3.0 + multi-disease beadchips 296 (GSAMD-24v3-0-EA) and Infinium chemistry. In summary this consists of three steps: (1) whole genome 297 amplification, (2) fragmentation followed by hybridisation, and (3) Genotype calls were carefully examined within GenomeStudio using manufacturer and published 51 recom-310 mendations, after excluding samples with low initial call rate (<90%) and reclustering the data thereafter.

Briefly, X and Y markers calls were all visually inspected and curated if necessary, as were those for au-312 tosomal markers with minor allele frequency > 1% displaying low Gentrain score, cluster separation, and 313 excess or deficit of heterozygous calls. Genotype-based sex determination was performed in GenomeStudio 314 and samples excluded if not matching records expectation. Five individuals with XXY genotypes were also 315 detected and excluded for downstream GWAS analyses. Genotypes were exported, in genome reference con-316 sortium human build 37 (GRCHb37) and Illumina "source" strand orientation, using the GenotypeStudio 317 plink-input-report-plugin-v2-1-4. A series of filtering steps was then applied using PLINK 1.9 leaving 318 2799 individuals and 479095 variants for further analyses (exclusion of samples with call rate < 95%, selection 319 of variants with call rate > 99% and minor allele frequency (MAF) > 1% and final samples selection using 320 a call rate > 97%).

Regions of high linkage disquilibrium (LD) defined in the UK Biobank 48 were excluded from the analysis, as well as SNPs with MAF<1% or missingness >1%. King 2.1 was used to construct a relation-328 ship matrix up to 3rd degree using the King command --kinship --degree 3 and then the function Unrelated individuals from the 1000 Genome Project dataset were calculated using the same procedure 338 described above, and both datasets were merged using the common SNPs. The merged genotyped data 339 was pruned with plink using a window of 1000 markers a step size of 50 and a r 2 of 0.05, leaving 92K 340 markers that were used to calculate the 20 first principal components with gcta 1.9. Ancestry for genomicc 341 individuals was inferred using ADMIXTURE 55 populations defined in 1000 genomes. When one individual 342 had a probability > 80% of pertaining to one ancestry, then the individual was assigned to this ancestry, Genotype files were converted to plus strand and SNPs with Hardy-Weinberg Equilibrium (HWE) p-348 value<10 -6 were removed. Imputation was calculated using the TOPMed reference panel. 18 and results were 349 given in grch38 human reference genome and plus strand. The imputed dataset was filtered for monogenic 350 and low imputation quality score (r 2 <0.4) using BCFtools 1.9. To perform GWAS, files in VCF format were 351 further filtered for r 2 >0.9 and converted to BGEN format using QCtools 1.3. (Table 1) . If age or deprivation status were missing for some individuals, the value was set 362 to the mean of their ancestry. GWAS were performed separately for each ancestry group.

Tests for association between case-control status and allele dosage at individuals SNPs were performed by 364 fitting logistic regression models using PLINK. 57 Independent analyses were performed for each ethnic group.

All models included sex, age, mean centered age squared, deprivation score decile of residential postcode, and 366 the first 10 genomic principal components as covariates.

Genomic principal components were computed on the combined sample of all UK Biobank and GenOMICC 368 participants. Specifically, 456,750 genetic variants were identified which were shared between the variants 369 contained in the called genotypes in the GenOMICC dataset and imputed UK Biobank genotypes, which 370 had an information score above 0.95 and a minor allele frequency above 1%. After merging genotypes at 371 these variants, variants were removed which had a minor allele frequency below 2.5%, a missingness rate 372 above 1.5%, showed departure from Hardy-Weinberg equilibrium with a p value below 10 -50 , or which were 373 13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 25, 2020. ethnicity. An extra filter was added to avoid bias for using a different genotyping method and imputation 379 panel between controls and cases. This could not be controlled for using regression because all cases and 380 all controls were genotyped using different methods. MAF for each ancestry were compared between UK 381 Biobank and gnomAD hg38 downloaded in August 2020. 59 SNPs were were removed from the GWAS results 382 specifically for each ethnicity following these two rules: (a) In SNPs with MAF > 10% in gnomAD, an absolute 383 difference of 5% between gnomAD and UK biobank controls MAF (b) In SNPs with MAF <10% in gnomAD, 384 a difference > 25% gnomAD MAF, between UK Biobank controls and gnomAD. To calculate differences 385 between UK Biobank European individuals and gnomAD allele frequencies, non Finnish-europeans gnomAD 386 allele frequencues were used, as European UK Biobank controls are mainly non-Finnish. and variants with depth<8 (the minimum depth for which 95% coverage can be expected) were filtered.

Individual VCF files were joined in a multi-sample VCF file for comparison with imputed variants. 1613 405 of these 1667 were used in the final GWAS. Samples were filtered and variants annotaed using bcftools 1.9.

VCF files obtained from imputation were processed in an identical manner. Alternative allele frequency was 407 calculated with PLINK 2.0 60 for both WGS and imputed data. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020 . . https://doi.org/10.1101 from the UK Biobank in August 2020, five individuals with matching inferred ancestry were sampled for each 420 GenOMICC participant as controls. After sampling each control, individuals related up to 3rd degree were 421 removed from the pool of potential further controls. GenOMICC EUR loci were defined by clumping function of PLINK 1.9 and clumping parameters r2 0.1 434 pval=5e-8 and pval2 0.01, and distance to the nearest gene was calculated using ENSEMBL grch37 gene 435 annotation. 436 No GWAS has been reported of critical illness or mortality in Covid-19. As a surrogate, to provide some 437 replication for our findings, replication analyses were performed using Host Genetics Initiative build 37, We performed transcriptome-wide association using the MetaXcan framework 25 and the GTExv8 eQTL 444 MASHR-M models available for download (http://predictdb.org/). First GWAS results were harmonised, 445 lifted over to hg38 and linked to 1000 Genomes reference panel using GWAS tools https://github.com/hakyi 446 mlab/summary-gwas-imputation/wiki/GWAS-Harmonization-And-Imputation. TWAS for whole blood and 447 lung were calculated using GWAS summary statistics for the European population GWAS and S-PrediXcan.

Resulting p-values were corrected using the Bonferroni correction to find significant gene associations. Testing genetic correlations with other phenotypes 527 We applied both the LD score regression (LDSC) 68 and high-definition likelihood (HDL) 26 methods to eval-528 uate the genetic correlations between Severe Covid-19 and 818 GWASed phenotypes stored on LD-Hub. 69 529 GWAS summary statistics were harmonized by the munge_sumstats.py procedure in the ldsc software. In 530 the HDL analysis, we estimated the SNP-based narrow-sense heritability for each phenotype, and for the 818 531 complex traits GWASs, those with SNPs less than 90% overlap with the HDL reference panel were removed. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . https://doi.org/10. 1101 inference in genome-wide association studies. Bioinformatics (Oxford, England) 26, 2867-73(2010) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 25, 2020. . https://doi.org/10.1101/2020.09.24.20200048 doi: medRxiv preprint 54.Yang, J., Lee, S.H., Goddard, M.E. & Visscher, P.M. GCTA: A tool for genome-wide complex trait analysis.

Identification of novel dipeptidyl peptidase 9 substrates by 753 two-dimensional differential in-gel electrophoresis

The 755 cytoplasmic peptidase dpp9 is rate-limiting for degradation of proline-containing peptides

Systematic review and meta-analysis identifies potential host therapeutic 759 targets in COVID-19

Heightened innate immune responses in the respiratory tract of covid-19 763 patients

Longitudinal covid-19 profiling associates il-1RA and il-10 with disease severity and rantes with mild disease

Modulation of ccr2 in rheumatoid arthritis: 770 A double-blind, randomized, placebo-controlled clinical trial

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC 775 WHO Clinical Characterisation Protocol: Prospective observational cohort study

Factors associated 780 with covid-19-related death using opensafely

An Open Access Resource for Identifying the Causes of a Wide Range of Complex 784 Diseases of Middle and Old Age

The genome analysis toolkit: A mapreduce framework for 787 analyzing next-generation dna sequencing data

Variant detection sensitivity and biases in 789 whole genome and exome sequencing

Illumina 791 human exome genotyping array clustering and quality control

Million veteran program: A mega-795 biobank to study genetic influences on health and disease

Robust relationship 55.Alexander, D.H. & Lange, K. Enhancements to the admixture algorithm for individual ancestry estimation

A note on exact tests of hardy-weinberg equilibrium

Tissue and functional genomic enrichment